drugset / Trial / NCT04003844
Study of Combined Therapy IVIG-SN 10% and Acetylsalicylic Acid in Kawasaki Disease
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of high-dose human Immunoglobulin G Intravenous (IGIV) 10% in subjects with Kawasaki diseases (KD).
Timeline
- Start
- 2019-02-01
- Primary completion
- 2019-11-22
- Completion
- 2019-11-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Immunoglobulin G | Protein / enzyme biologic | 2 g/kg | Intravenous |
| Background | Aspirin | Small molecule | — | — |